# Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer

> **NCT01881451** · — · TERMINATED · sponsor: **British Columbia Cancer Agency** · enrollment: 5 (actual)

## Conditions studied

- Ovarian Cancer
- Ovarian Neoplasms

## Interventions

- **DRUG:** 18F-EF5 PET/CT scan
- **PROCEDURE:** Optional biopsy

## Key facts

- **NCT ID:** NCT01881451
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08
- **Primary completion:** 2016-03
- **Final completion:** 2020-05
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Due to slow accrual and access to the study drug.
- **Last updated:** 2022-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01881451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01881451, "Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01881451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*